<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        259-186-08
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2008
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ROTHACIN 100MG SUPPOSITORIES
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        INDOMETACIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Rectal use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Suppository
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        13.2
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Rothacin</strong> contain the active ingredient indomethacin.</p><p>This belongs to a group of medicines known as &lsquo;non-steroidal anti-inflammatory agents&rsquo; or NSAlDs.These work by reducing the body&rsquo;s ability to produce Inflammation, which may cause pain and discomfort.</p><p>Your doctor has prescribed <strong>Rothacin</strong> for you because you are suffering from one of the following:</p><p>&middot;&nbsp; Rheumatoid arthritis (disease mainly of the joints)</p><p>&middot;&nbsp; Osteoarthritis (disease of the joints)</p><p>&middot;&nbsp; Ankylosing spondylitis (a form of arthritis which mainly affects the back)</p><p>&middot;&nbsp; Pain, inflammation, and swelling following orthopaedic surgery.</p><p>&middot;&nbsp; Musculoskeletal disorders (muscles and bone disorders).</p><p>&middot;&nbsp; Period pain.</p><p>&middot;&nbsp; Low back pain.</p><p>&middot;&nbsp; Disease of the hip joint.</p><p>&middot;&nbsp; Acute gouty arthritis (a form of arthritis in which crystals build up in the joints).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Rothacin </strong></p><p>&middot;&nbsp; &nbsp;If you are hypersensitive (allergic) to indomethacin or any of the other ingredients in <strong>Rothacin</strong> (for example, if you have experienced breathing difficulties, skin rashes which look like nettle rash, or a runny nose) or If you are hypersensitive to aspirin or another non-steroidal anti-inflammatory medicine. A full list of the ingredients is in section 6 &ndash; Further information.</p><p>&middot;&nbsp; If you have a peptic ulcer (ulcer in your stomach or duodenum) or bleeding in your stomach, or have had two episodes of peptic ulcers, stomach bleeding or perforation.</p><p>&middot;&nbsp; If you are suffering from inflammation of the rectum causing soreness, bleeding and sometimes a discharge of mucus and/or pus from your anus.</p><p>&middot;&nbsp; If you have polyps (soft fleshy swellings that grow inside the nose) in your nose, associated with itching, nettle rash, wheezing, or swelling of the face, lips, tongue and/or throat or difficulties in swallowing or breathing.</p><p><strong>Take special care with Rothacin</strong></p><p>&middot;&nbsp; If you are epileptic</p><p>&middot;&nbsp; If you have Parkinson&rsquo;s disease</p><p>&middot;&nbsp; If you have a psychiatric problem</p><p>&middot;&nbsp; If you have heart disease, high blood pressure or have a tendency for fluid retention</p><p>&middot;&nbsp; If you are being treated for infection or you have a fever</p><p>&middot;&nbsp; If you know you suffer from asthma, digestive tract, liver or kidney disease, diabetes or heart failure</p><p>&middot;&nbsp; If you have a problem with your blood clotting.</p><p>&middot;&nbsp; If you are having blood tests, make sure that the doctor doing them knows that you are taking <strong>Rothacin</strong>.</p><p>&middot;&nbsp; If you have rheumatoid arthritis your doctor may want to examine your eyes at intervals during your treatment with <strong>Rothacin</strong>. You should see your doctor if you notice any change in your vision</p><p><strong>Risk of heart attack or stroke </strong></p><p>Medicines such as <strong>Rothacin</strong> may be associated with a small increased risk of heart attack (&lsquo;Myocardial Infarction&rsquo;) or stroke. Any risk is likely with high doses and prolonged treatment. Do not exceed the recommended dose or duration of treatment. You might be at risk of these conditions (for example If you have high blood pressure, diabetes or high cholesterol or are a smoker) you should discuss your treatment with your doctor or pharmacist.</p><p><strong>Taking other medicines </strong></p><p>Tell your doctor or pharmacist if you are taking any of the following:</p><p>&middot;&nbsp; Aspirin or similar medicines.</p><p>&middot;&nbsp; Other non-steroidal anti-inflammatory medicines including diflunisal.</p><p>&middot;&nbsp; Anticoagulants, which thin the blood.</p><p>&middot;&nbsp; A medicine for gout called probenecid.</p><p>&middot;&nbsp; Methotrexate, a drug used in the treatment of cancer, severe skin disease and rheumatoid arthritis.</p><p>&middot;&nbsp; Cyclosporin, a drug used to prevent the body from rejecting a recent organ or bone-marrow transplant, and to treat severe skin disease and rheumatoid arthritis.</p><p>&middot;&nbsp; Lithium for treatment of mental disorders.</p><p>&middot;&nbsp; Diuretics (water tablets).</p><p>&middot;&nbsp; Cardiac glycosides, such as digoxin, medicines used in the treatment of congestive heart failure and certain alterations of heart rhythm.</p><p>&middot;&nbsp; Antihypertensive medicines for the treatment of high blood pressure.</p><p>&middot;&nbsp; A nasal decongestant called phenylpropanolamine usually found in over-the-counter cold relief preparations.</p><p>&middot;&nbsp; Corticosteroid drugs, including anti-Inflammatory and replacement therapies.</p><p>&middot;&nbsp; Mifepristone, a treatment used in emergency for termination of pregnancy.</p><p>&middot;&nbsp; Antibiotics from the quinolone group of antibiotics.</p><p><strong>Pregnancy and Breast-feeding </strong></p><p>Ask your doctor or pharmacist for advice before taking this medicine. If you are pregnant or planning to become pregnant or if you are breastfeeding, <strong>Rothacin</strong> may make it more difficult to become pregnant. You should inform your doctor if you are planning to become pregnant or if you have problems becoming pregnant.</p><p><strong>Driving and using machines </strong></p><p><strong>Rothacin</strong> can cause headaches, dizziness, drowsiness and visual disturbances in some people. If this happens to you, avoid activities which require you to be alert; for example, driving a car and operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use <strong>Rothacin</strong> exactly as your doctor has told you.</p><p>You should check with your doctor or pharmacist if you are not sure.</p><p>Suppositories must not be taken by the mouth.</p><p>They are to be placed in the rectum (back passage). Empty your bowels (if necessary) before use. Remove the suppository from the foil and, lying on your back or your side with your knees bent up, push the suppository- pointed end first - up into your back passage. Lie still for a minute or so, and then wash your hands. The suppository should remain in place and dissolve completely.</p><p>The amount you use will depend upon your condition.</p><p><strong>Dosage:</strong></p><p>The usual adult dosage is one suppository 100mg or two suppositories 50mg to be inserted into the rectum once or twice a day. One should be used at bedtime and if another is necessary it should be used in the morning.</p><p><strong>Not recommended for use in children. </strong></p><p><strong>If you use more Rothacin than you should </strong></p><p>If you use too many suppositories by mistake or someone else accidentally uses your suppositories, contact your doctor immediately or go to the nearest casualty department.</p><p><strong>If you forget to use Rothacin </strong></p><p>If you forget to take the suppository, take it as soon as you remember. If it is nearly time for your next dose, just carry on with the next dose as normal. Do not use an extra suppository to make up for forgotten doses.</p><p><strong>If you stop using Rothacin </strong></p><p>You should use <strong>Rothacin</strong> suppositories for as long as your doctor tells you to. It may be dangerous to stop using them without your doctor&rsquo;s advice.</p><p><strong>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</strong></p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, <strong>Rothacin</strong> can cause side effects although not everybody gets them.</p><p><strong>If you experience an allergic reaction, STOP TAKING the medicine and seek immediate medical help: </strong></p><p><strong>Symptoms of allergic reactions are: </strong></p><p>&middot;&nbsp; Itching;</p><p>&middot;&nbsp; Rashes;</p><p>&middot;&nbsp; Sensitivity to sunlight;</p><p>&middot;&nbsp; Loss of hair; swollen face, lips, tongue and throat;</p><p>&middot;&nbsp; Difficulty in breathing and swallowing; inflammation of blood or lymph glands (lymph glands are all over the body but are noticeable in the neck and armpit when swollen as bean shaped);</p><p>&middot;&nbsp; Severe light headedness or dizziness due to a rapid fall in blood pressure.</p><p>&middot;&nbsp; The allergic reaction may include problems with the liver, kidneys or blood cells (see below for liver, kidney and blood problems).</p><p><strong>If you suffer from any of the following at any time during your treatment STOP TAKING the medicine and seek immediate medical help: </strong></p><p>&middot;&nbsp; Pass blood in your faeces (stools/motions)</p><p>&middot;&nbsp; Pass black tarry stools</p><p>&middot;&nbsp; Vomit any blood or dark particles that look like coffee grounds</p><p><strong>STOP TAKING the medicine and tell your doctor if you experience: </strong></p><p>&middot;&nbsp; Indigestion or heartburn</p><p>&middot;&nbsp; Abdominal pain (pains in your stomach) or other abnormal stomach symptoms.</p><p><strong>Medicines such as Indomethacin may be associated with a small increased risk of heart attack (&lsquo;Myocardial Infarction&rsquo;) or stroke. </strong></p><p><strong>Other side effects include: </strong></p><p><strong><u>Problems with the central nervous system: </u></strong></p><p>&middot;&nbsp; Headache, dizziness, light-headedness, depression, vertigo (sensation that things around you are moving) and tiredness (including feeling unwell and listlessness).</p><p>&middot;&nbsp; Reactions reported infrequently include anxiety, confusion, fainting, drowsiness, fits, coma, peripheral neuropathy which may be experienced as loss of sensation, numbness, tingling, and pricking sensations, sensitivity to touch, or muscle weakness, involuntary muscle movements, sleeplessness, hallucinations (seeing or hearing things that are not there), mental disorders including a loss of personal identity. Rarely, pins and needles, speech problems, worsening of epilepsy and parkinsonism symptoms (symptoms that mimic those of Parkinson&rsquo;s disease such as tremor or abnormal movements). If these side effects are severe you may need to stop treatment with this medicine. You should talk to your doctor.</p><p><strong><u>Problems with the digestive system: </u></strong></p><p>&middot;&nbsp; The most frequent reactions are nausea, loss of appetite, vomiting, trapped wind, constipation, and diarrhoea.</p><p>&middot;&nbsp; Reactions reported infrequently include inflammation of the mouth and stomach, wind, narrowing and/or obstruction of the intestines which may be seen as a swollen abdomen, and vomiting.</p><p><strong><u>Liver disorders: </u></strong></p><p>&middot;&nbsp; Rarely, inflammation of the liver and jaundice, symptoms of which may be yellowing of the eyes and skin.</p><p><strong><u>Heart and kidney disorders: </u></strong></p><p>&middot;&nbsp; High or low blood pressure, abnormal heartbeat, chest pain, palpitations, heart failure, kidney problems which can lead to water retention, reduction in the amount of urine passed, protein and blood in the urine, increased levels of urea in the blood.</p><p>&middot;&nbsp; These changes in urine and blood composition would normally be picked up in urine or blood tests.</p><p><strong><u>Blood disorders: </u></strong></p><p>&middot;&nbsp; Infrequently, blood disorders which are usually detected in blood tests, but may be seen as pale skin, tiredness, fever, sore throat and mouth, small red spots on the skin, bruising or prolonged bleeding after Injury. Blood disorders such as leucopenia and anaemia may be seen with symptoms of severe chills, mouth ulcers, headache, shortness of breath and dizziness.</p><p><strong><u>Eye disorders:</u></strong></p><p>&middot;&nbsp; Infrequently, blurred vision, double vision, pain in the eye and other visual disturbances.</p><p><strong><u>Problems with the ear:</u></strong></p><p>&middot;&nbsp; &nbsp;Ringing in the ears and other hearing disturbances, including deafness rarely.</p><p><strong>Other side effects: </strong></p><p>&middot;&nbsp; Bleeding from the vagina in women;</p><p>&middot;&nbsp; Increased levels of sugar in the blood, sugar in the urine, high levels of potassium in the blood, which are generally diagnosed by laboratory tests;</p><p>&middot;&nbsp; Flushing and sweating;</p><p>&middot;&nbsp; Bleeding from the nose;</p><p>&middot;&nbsp; Breast changes including enlargement and tenderness in men and women;</p><p>&middot;&nbsp; Ulcers in the lining of the mouth.</p><p><strong>Side effects associated with the use of Indomethacin suppositories </strong></p><p>&middot;&nbsp; Bleeding, inflammation, burning pain, discomfort, itching or the feeling of a full back passage.</p><p><strong>Laboratory tests </strong></p><p>Misleading results have been seen with patients having a Dexamethasone suppression test (DST) while using Indomethacin.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</strong></p><p><strong>&nbsp;</strong></p><p><strong><u>To report any side effect(s):</u></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax:</strong>&nbsp;+966-11-205-7662</p><p><strong>Call NPC at</strong>&nbsp;+966-11-2038222,&nbsp;</p><p><strong>Exts:</strong>&nbsp;2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone:</strong>&nbsp;8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong>&nbsp;www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp; Do not use<strong> Rothacin</strong> after the expiry date which is stated on the carton.</p><p>-&nbsp; Store below 30&ordm;C, protected from heat.</p><p>-&nbsp; Do not use<strong> Rothacin</strong> if you notice any visible sign of deterioration.</p><p>-&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is Indomethacin. Each suppository contains 50mg or 100mg of Indomethacin.</p><p>The other ingredients are: Hard fat and polyoxyl 40 stearate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Rothacin suppositories are available in packs of 10 or 100 suppositories.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
09/08/2015

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي <strong>روثاسين </strong>على<strong> </strong>المادة الفعالة إندوميثاسين، والتي تنتمي إلى مجموعة من الأدوية التي تعرف باسم &quot;أدوية مضادات الالتهاب &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;الغير ستيرويدية&quot;. حيث تعمل عن طريق تقليل قدرة الجسم على تكوين الالتهابات، التي تتسبب في الإحساس بالألم وعدم الراحة.</p><p>&nbsp;سوف يصف لك طبيبك المعالج <strong>روثاسين</strong> إذا كنت تعاني&nbsp; من أحد الأمراض التالية:</p><p>&middot; التهاب المفاصل الروماتويدي (مرض يصيب المفاصل بصفة أساسية).</p><p>&middot; هشاشة العظام (مرض يصيب المفاصل).</p><p>&middot; التهاب الفقار القسطي (نوع من أنواع التهاب المفاصل الذي يؤثر وبصفة أساسية على الظهر).</p><p>&middot; ألم، التهاب، و علاج التورم الذي يلي إجراء العمليات الجراحية.</p><p>&middot; اضطرابات العضلية الهيكلية (اضطراب في العضلات والعظام).</p><p>&middot; ألم الدورة الشهرية.</p><p>&middot; ألم أسفل الظهر.</p><p>&middot; مرض مفصل الورك.</p><p>&middot; التهاب حاد في المفاصل الناجم عن داء النقرس (نوع من أنواع التهاب المفاصل حيث يتم تراكم بلورات في المفاصل).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>يجب عدم استعمال روثاسين في الحالات التالية:</strong></p><p>&middot; &nbsp;إذا كنت تعاني من فرط الحساسية (الحساسية) تجاه إندوميثاسين أو أي من المكونات الأخرى في <strong>روثاسين</strong> (على سبيل المثال، إذا كنت تعاني من صعوبة في التنفس، طفح جلدي الذي يشبه الطفح القراص، أو سيلان الأنف) أو إذا كنت تعاني من حساسية تجاه الأسبرين أو أدوية مضادات الالتهاب الغير ستيرويدية الأخرى. جميع المكونات الأخرى مذكورة في قسم 6- معلومات إضافية.</p><p>&middot; &nbsp;إذا كنت تعاني من قرحة هضمية (قرحة المعدة أو الإثنى عشر) أو حدوث نزيف في المعدة، أو قد عانيت من تكرار حدوث قرحة المعدة &nbsp;مرتين، نزيف أو انثقاب في المعدة</p><p>&middot; إذا كنت تعاني من التهاب في المستقيم والذي يؤدي إلى حدوث تقرحات، نزيف والذي يكون مصحوب أحياناً بإفراز المخاط و/أو خروج صديد من الفتحة الشرجية.</p><p>&middot; إذا كنت تعاني من ورم حميد في الأنف (تورم لحمي أملس الذي ينمو داخل الأنف)، مصحوباً بحكة، طفح قراص، أزيز، أو تورم الوجه، الشفتين، اللسان و/أو الحلق أو صعوبة في البلع أو التنفس .</p><p><strong>رعاية خاصة قبل استعمال روثاسين</strong></p><p>&middot; إذا كنت تعاني من نوبات الصرع</p><p>&middot; إذا كنت تعاني من مرض الباركنسون</p><p>&middot; إذا كنت تعاني من مشاكل نفسية</p><p>&middot; إذا كنت تعاني من أمراض القلب، ارتفاع ضغط الدم أو لديك قابلية لاحتباس السوائل</p><p>&middot; إذا كنت سوف تخضع لعلاج العدوى أو تعاني من الحمى</p><p>&middot; إذا كنت على دراية بأنك تعاني من داء الربو، أمراض الجهاز الهضمي، أمراض الكبد أو الكلى، داء السكري أو فشل القلب</p><p>&middot; إذا كنت تعاني من مشاكل في تجلط الدم.</p><p>&middot; إذا كنت سوف تخضع لإجراء فحوصات في الدم، كن حريصاً على إخبار الطبيب المعالج الذي سوف يقوم بعمل تلك الفحوصات لك بأنك تستعمل <strong>روثاسين</strong>.</p><p>&middot; إذا كنت تعاني من التهاب المفاصل الروماتويدي فقد يحتاج طبيبك المعالج للقيام بفحص العينين بشكل دوري أثناء فترة العلاج <strong>بروثاسين</strong>. &nbsp;يجب عليك مراجعة طبيبك المعالج إذا لاحظت أي تغيير في الرؤية لديك.</p><p><strong>إحتمالية التعرض لخطر حدوث الأزمة القلبية أو السكتة الدماغية</strong></p><p>إن الأدوية على سبيل المثال <strong>روثاسين</strong> قد تكون مصحوبة باحتمالية حدوث زيادة طفيفة<strong> </strong>لخطر الإصابة<strong> </strong>بأزمة قلبية (إحتشاء عضلة القلب) أو السكتة الدماغية. من المحتمل حدوث أي مخاطر مع استعمال جرعات عالية ولفترة زمنية طويلة. يجب عدم تجاوز الجرعات الموصى بها أو مدة&nbsp; العلاج. يجب عليك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت عرضة لخطر الإصابة بتلك الحالات (على سبيل المثال إذا كنت تعاني من ارتفاع ضغط الدم، داء السكري أو ارتفاع نسبة الكوليسترول أو كنت مدخناً).</p><p><strong>تناول روثاسين مع الأدوية الأخرى</strong></p><p>يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول الأدوية التالية:</p><p>&middot; اسبرين أو الأدوية الأخرى المماثلة.</p><p>&middot; أدوية مضادات الالتهاب الغير ستيرويدية الأخرى بما في ذلك ديفلونيزال.</p><p>&middot; مضادات تجلط الدم، التي تعمل على ترقيق الدم.</p><p>&middot; دواء لعلاج النقرس يعرف باسم بروبنسيد.</p><p>&middot; ميثوتريكسات، دواء يستخدم لعلاج السرطان، مرض جلدي شديد والتهاب المفاصل الرماتويدي.</p><p>&middot; سيكلوسبورين ، دواء يستخدم لمنع الجسم من رفض الأعضاء التي تم زرعها مؤخراً أو في زراعة نخاع العظام، ولعلاج أمراض الجلد الشديدة والتهاب المفاصل الروماتويدي.</p><p>&middot; ليثيوم لعلاج الإضطرابات النفسية.</p><p>&middot; مدرات البول.</p><p>&middot; &nbsp;جليكوسيدات القلبية، على سبيل المثال ديجوكسين، دواء يستخدم لعلاج فشل القلب الاحتقاني وتغيرات معينة في نظم القلب.</p><p>&middot; الأدوية التي تعمل على خفض ضغط الدم والتي تستخدم لعلاج ارتفاع ضغط الدم.</p><p>&middot; الأدوية المزيلة للاحتقان الأنف تعرف باسم فينيل بروبانولامين عادةً ما توجد مع المستحضرات التي تستخدم لتخفيف نزلات البرد التي تصرف بدون وصفة طبية.</p><p>&middot; أدوية كورتيكوستيرويد، بما في ذلك مضادات الالتهابات والعلاج البديل.</p><p>&middot; ميفبريستون، يستخدم في علاج في الحالات الطارئة لإنهاء الحمل.</p><p>&middot; &nbsp;المضادات الحيوية من مجموعة كينيولون.</p><p>&nbsp;<strong>الحمل والرضاعة الطبيعية</strong></p><p>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذين تتعاملين معه لطلب النصيحة قبل تناول هذا الدواء. إذا كنت حاملاً، أو تخططين كي تصبحين حاملاً أو ترضعين طفلك رضاعة طبيعية، قد يكون من الصعب أن تصبحين حاملاً مع استعمال <strong>روثاسين. </strong>يجب عليك إخبار طبيبك المعالج إذا كنت تخططين لكي تصبحين حاملاً<strong> </strong>أو كنت تعانين من مشاكل لكي تصبحين حاملاً.</p><p><strong>القيادة واستخدام الآلات</strong></p><p>قد يسبب <strong>روثاسين </strong>صداع<strong>، </strong>دوخة، نعاس، واضطرابات في الرؤية لدى بعض الأشخاص. إذا حدث ذلك لك، فيرجى منك تجنب الأنشطة التي تحتاج إلى تركيز ذهني على سبيل المثال، قيادة السيارات وتشغيل الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يرجى منك دائماً استعمال <strong>روثاسين </strong>بدقة تبعاً لتعليمات طبيبك المعالج.</p><p>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا لم تكن متأكداً من طريقة الاستعمال.</p><p>يجب عدم استعمال التحاميل عن طريق الفم.</p><p>يتم استعمال التحميلة عن طريق فتحة المستقيم. يجب عليك إفراغ الأمعاء (إذا لزم الأمر) قبل الاستعمال. قم بإزالة التحميلة من غلاف الفويل، قم بالاستلقاء على ظهرك أو على الجانب مع ثني ركبتيك إلى أعلى. قد بادخال الطرف المدبب من التحميلة&nbsp; إلى فتحة المستقيم. ابقى مستلقياً لمدة دقيقة واحدة أو أكثر، يجب عليك بعد ذلك غسل يديك. يجب أن تبقى التحميلة مكانها إلى أن تذوب تماماً.</p><p>يعتمد مقدار الجرعة على مدى تطور حالتك الصحية.</p><p><strong>الجرعة:</strong></p><p>الجرعة الاعتيادية للبالغين هي تحميلة واحدة بمقدار 100 ملغم أو تحميلتين بمقدار 50 ملغم ويتم استعمالها عن طريق فتحة المستقيم مرة أو مرتين في اليوم. يجب استعمال تحميلة واحدة في وقت النوم، إذا لزم الأمر لاستعمال تحميلة أخرى، فيفضل استعمالها في الصباح</p><p><strong>لا يوصى باستعمال تحاميل روثاسين من قبل الأطفال</strong></p><p><strong>إذا استعملت روثاسين أكثر مما يجب</strong></p><p>إذا استعملت العديد من التحاميل أو استعمل أي شخص آخر التحاميل الخاصة بك عن طريق الخطأ، يرجى منك التواصل مع طبيبك المعالج على الفور أو توجه إلى قسم طوارئ في أقرب مستشفى.</p><p><strong>إذا سهوت عن استعمال روثاسين</strong></p><p>إذا سهوت عن استعمال إحدى التحاميل، يجب استعمالها في أقرب وقت ممكن حال تذكرها. إذا اقترب موعد الجرعة التالية، عليك فقط الاستمرار باستعمال الجرعة التالية كالمعتاد. يجب عدم استعمال تحميلة إضافية &nbsp;لتعويض الجرعات التي سهوت عنها.</p><p><strong>إذا توقفت عن استعمال روثاسين</strong></p><p>يجب عليك استعمال تحاميل <strong>روثاسين</strong> خلال المدة التي أوصى بها طبيبك المعالج. قد يكون من الخطورة التوقف عن استعماله بدون استشارة طبيبك المعالج.</p><p><strong>يرجى منك التواصل مع طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا كان لديك أي اسئلة إضافية حول استعمال هذا الدواء</strong><strong>.</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما هو عليه الحال مع جميع الأدوية، قد يتسبب <strong>روثاسين</strong> في حدوث تأثيرات جانبية، على الرغم من أنها قد لا تحدث لكل شخص.</p><p><strong>&nbsp;</strong><strong>إذا عانيت أي من التفاعلات التحسسية، فيرجى منك التوقف عن تناول هذا الدواء وطلب المساعدة الطبية على الفور:</strong></p><p><strong>أعراض التفاعلات التحسسية هي:</strong></p><p>&middot; حكة</p><p>&middot; طفح جلدي</p><p>&middot; الحساسية تجاه ضوء الشمس</p><p>&middot; سقوط الشعر، تورم الوجه، الشفتين، اللسان والحلق</p><p>&middot; صعوبة في التنفس أو البلع، التهاب في الدم أو الغدد الليمفاوية (توجد الغدد الليمفاوية في جميع أنحاء الجسم ولكن توجد بصورة ملوحظة في منطقة الرقبة والإبط حيث تكون على شكل البازلاء عندما تتورم)</p><p>&middot; دوار شديد أو دوخة بسبب انخفاض سريع في ضغط الدم</p><p>&middot; التفاعلات التحسسية بما في ذلك مشاكل في الكبد، الكلى أو خلايا الدم (انظر أدناه مشاكل الكبد، الكلى والدم)</p><p><strong>يرجى منك التوقف عن استعمال هذا الدواء وطلب المساعدة الطبية على الفور إذا عانيت أياً من التالي في أي وقت أثناء فترة العلاج:</strong></p><p>&middot; براز مصحوب بدم</p><p>&middot; براز أسود قطراني اللون</p><p>&middot; &nbsp;تقيؤ أي دم أو حبيبات سوداء تشبه حبيبات القهوة</p><p><strong>يرجى منك التوقف عن استعمال هذا الدواء وإخبار طبيبك المعالج إذا عانيت من الآتي:</strong></p><p>&middot; عسر هضم أو حرقة المعدة</p><p>&middot; ألم بالبطن (آلام بالمعدة) أو أعراض غير طبيعية في المعدة.</p><p><strong>قد تكون الأدوية على سبيل المثال إ</strong><strong>ندوميثاسين </strong><strong>مصحوبة بزيادة طفيفة لخطر الإصابة بالأزمة القلبية (إحتشاء عضلة القلب)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;أو سكتة دماغية. </strong></p><p><strong>التأثيرات الجانبية الأخرى تتضمن على:</strong></p><p><strong><u>مشاكل في الجهاز العصبي المركزي:</u></strong></p><p>&middot; صداع، دوخة، اكتئاب، دوار (الشعور بأن الأشياء تتحرك حولك) والشعور بالتعب (بما في ذلك التوعك والشعور بالكسل)</p><p>&middot; تم تسجيل حدوث تفاعلات بصورة غير متكررة وتتضمن قلق، ارتباك، إغماء، النعاس، إختلاجات، غيبوبة، اعتلال العصبي المحيطي حيث قد تعاني من فقدان الإحساس، خدر، تنميل، شعور بالوخز، حساسية تجاه اللمس، أو ضعف العضلات، حركات عضلية لا إرادية، أرق، هلوسة (رؤية أو سماع أشياء ليس لها وجود)، اضطرابات نفسية بما في ذلك عدم التعرف على الهوية. ونادراً تم تسجيل، الشعور بالوخز شبيه بوخز الإبر والدبابيس، مشاكل في الكلام، تفاقم حالة الصرع وأعراض الشلل الرعاش (الأعراض التي تحاكي مرض باركنسون على سبيل المثال ارتعاش أو حركات غير طبيبعية). قد تحتاج إلى إيقاف العلاج مع هذا الدواء إذا كانت تلك التأثيرات الجانبية شديدة. يرجى منك التحدث مع طبيبك المعالج.</p><p><strong><u>مشاكل في الجهاز الهضمي:</u></strong></p><p>&middot; التفاعلات الأكثر تكراراً هي الغثيان، فقدان الشهية، تقيؤ، غازات، إمساك، وإسهال</p><p>&middot; تتضمن التفاعلات التي سجلت بصورة غير متكررة على التهاب الفم والمعدة، ريح، ضيق و/أو انسداد الأمعاء التي قد يظهر في صورة تورم في البطن، وتقيؤ</p><p><strong><u>اضطرابات الكبد:</u></strong></p><p>&middot; بصورة نادرة، حدوث التهاب في الكبد ويرقان، قد تتضمن الأعراض على اصفرار العينين والجلد.</p><p><strong><u>اضطرابات القلب والكلى:</u></strong></p><p>&middot; ارتفاع أو انخفاض ضغط الدم، اضطراب نبضات القلب، ألم في الصدر، خفقان، فشل القلب، مشاكل في الكلى التي من الممكن أن تؤدي إلى حدوث احتباس الماء، التبول بكميات قليلة، ظهور البروتين والدم في البول، ارتفاع مستويات اليوريا في الدم.</p><p>&middot; يتم الكشف عن تلك التغيرات بصورة طبيعية في البول ومكونات الدم عن طريق إجراء فحوصات الدم أو البول.</p><p><strong><u>اضطرابات الدم:</u></strong></p><p>&middot; تحدث الاضطرابات في الدم بصورة غير متكررة، حيث يتم عادةً التعرف عليها عن طريق إجراء فحوصات الدم، ولكن قد تظهر في صورة جلداً شاحباً، تعب، حمى، التهاب الحلق والفم، ظهور بقع حمراء اللون على الجلد، كدمات أو حدوث نزيف بعد الإصابة لفترة طويلة. اضطرابات في الدم على سبيل المثال نقص كريات الدم البيضاء وفقر الدم الذي قد يكون مصحوباً بالأعراض على سبيل المثال قشعريرة شديدة، تقرحات فموية، صداع، ضيق في التنفس ودوخة.</p><p><strong><u>اضطرابات في العين:</u></strong></p><p>&middot; &nbsp;عدم وضوح الرؤية، إزدواج الرؤية، ألم في العين واضطرابات بصرية أخرى، يحدث ذلك بصورة غير متكررة</p><p><strong><u>مشاكل في الأذن:</u></strong></p><p>&middot; طنين في الأذنين واضطرابات سمعية أخرى، بما في ذلك حدوث فقدان السمع بصورة نادرة.</p><p><strong>التأثيرات الجانبية الأخرى:</strong></p><p>&middot; نزيف من&nbsp; المهبل لدى النساء؛</p><p>&middot; زيادة مستويات السكرفي الدم، ظهور سكر في البول، ارتفاع مستويات البوتاسيوم في الدم، حيث يتم الكشف عنها بصورة عامة عن طريق الفحوصات المختبرية .</p><p>&middot; توهج وتعرق</p><p>&middot; نزيف من الأنف</p><p>&middot; تغيرات في الثدي بما في ذلك تضخم الثدي أو الشعور بالألم عند الضغط على الثدى لدى الذكور والإناث</p><p>&middot; تقرحات في بطانة الفم</p><p><strong>التأثيرات الجانبية المصاحبة لإستعمال تحاميل إ</strong><strong>ندوميثاسين&nbsp; </strong></p><p>&middot; حدوث نزيف، التهاب، ألم مصحوب بالشعور بالحرقة، شعور بعدم الراحة، حكة أو الشعور الملح للذهاب إلى دورة المياه.</p><p><strong>الفحوصات المختبرية </strong></p><p>قد تم ملاحظة نتائج خاطئة لدى المرضى الذين يقومون بعمل&nbsp; فحص التثبيط بالديكساميثازون أثناء فترة استعمال إندوميثاسين.</p><p><strong>في حال زيادة حدة الأعراض الجانبية، أو إذا لاحظت حدوث تأثيرات جانبية أخرى لم تذكر في هذه النشرة، يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه.</strong></p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong><br /><strong>&nbsp;المركز الوطني للتيقظ والسلامة الدوائية</strong></p><p><strong>رقم الفاكس: </strong>7662-205-11-966+</p><p><strong>يرجى الاتصال بالمركز الوطني للتيقظ والسلامة الدوائية على:</strong> 2038222-11-966+<strong>&nbsp; </strong></p><p><strong>وصلة هاتف:</strong>2340-2334-2354-2353-2356-2317</p><p><strong>الهاتف المجاني: </strong>8002490000</p><p><strong>البريد الإلكتروني:</strong><strong> </strong>&nbsp;npc.drug@sfda.gov.sa</p><p><strong>الموقع الإلكتروني:</strong> www.sfda.gov.sa/npc</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>-&nbsp;&nbsp; يحفظ هذا الدواء في مكان آمن بعيد عن مرأى ومتناول الأطفال.</p><p>-&nbsp;&nbsp; يجب عدم تناول <strong>روثاسين </strong>بعد تاريخ انتهاء الصلاحية المذكورعلى العبوة.</p><p>-&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30&deg;م، بعيداً عن الحرارة.</p><p>-&nbsp;&nbsp; يجب عدم تناول &nbsp;<strong>روثاسين</strong> إذا لاحظت وجود علامات تلف واضحة.</p><p>-&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي إندوميثاسين. تحتوي كل تحميلة على 50 ملغم أو 100 ملغم من إندوميثاسين.</p><p>المكونات الأخرى: دهن صلب واستيارات بوليوكسيل 40.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;تتوفر تحاميل <strong>روثاسين</strong> في عبوات تحتوي كلاً منها على 10 تحاميل أو 100 تحميلة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
09/08/2015

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Rothacin 100mg Suppositories
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each suppository contains: 
Item no.	Material Name	Scale
(mg/suppository)
	Active Ingredient:	
1.		Indomethacin 	100.00
		
	Inactive Ingredients:	
1.		Hard fat (estaram 8770 H15)	1696.000
2.		Polyoxyl 40 stearate	4.000







For a full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Suppositories
Description: Smooth, creamy white to cream coloured, torpedo shaped suppository.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Rothacin</strong> has non-steroidal analgesic and anti-inflammatory properties.</p><p>It is indicated for the following conditions:</p><p>&middot;&nbsp;&nbsp; Active stages of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, degenerative joint disease of the hip, acute musculoskeletal disorders, gout and lumbago.</p><p>&middot;&nbsp;&nbsp; Inflammation, pain and oedema following orthopaedic procedures.</p><p>&middot;&nbsp;&nbsp; Treatment of pain and associated symptoms of primary dysmenorrhoea.</p><p>&middot;&nbsp;&nbsp; Since indomethacin is not a simple analgesic, its use should be limited to the above conditions.</p><p><strong>Rothacin</strong> may be used where night pain and morning stiffness are prominent. One suppository at bedtime frequently gives relief from pain and stiffness for 13-16 hours after administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em><u>Adults only:</u></em></strong>&nbsp;To be inserted rectally. One suppository (100mg) to be inserted at night and repeated in the morning, if necessary.</p><p><strong><em><u>Elderly:&nbsp;</u></em></strong>The elderly are at increased risk of the serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for GI bleeding during NSAID therapy.</p><p><strong><em><u>Children:</u></em></strong><em>&nbsp;</em>Safety for use in children has not been established.</p><p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4).</p><p><strong><em>Method of Administration</em></strong></p><p>For rectal administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	Hypersensitivity to indomethacin or to any of the excipients.
	NSAIDs are contraindicated in patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to ibuprofen, aspirin or other non-steroidal anti-inflammatory drugs.
	Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding)
	Severe heart failure, hepatic failure and renal failure (see section 4.4).
	Not to be used in patients with nasal polyps.
	During the last trimester of pregnancy (see section 4.6).
	Safety in children has not been established.
	History of proctitis, haemorrhoids or rectal bleeding.
	History of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2, and GI and cardiovascular risks below).</p><p>The use of indomethacin with concomitant NSAIDs including cyclooxygenase-2 selective inhibitors, should be avoided (see section 4.5)</p><p><strong><em>Cardiovascular, Renal and Hepatic Impairment:</em></strong></p><p>The administration of an NSAID may cause a dose dependent reduction in prostaglandin formation and precipitate renal failure. Patients at greatest risk of this reaction are those with impaired renal function, cardiac impairment, liver dysfunction, those taking diuretics and the elderly. Renal function should be monitored in these patients (see also section 4.3).</p><p>In patients with reduced renal blood flow where renal prostaglandins play a major role in maintaining renal perfusion, administration of a NSAID may precipitate overt renal decompensation. Patients at greatest risk of this reaction are those with renal or hepatic dysfunction, diabetes mellitus, advanced age, extracellular volume depletion, congestive heart failure, sepsis or concomitant use of any nephrotoxic drug. Indomethacin should be given with caution and renal function should be monitored in any patient who may have reduced renal reserve. Discontinuation of NSAID therapy is usually followed by recovery to the pretreatment state.</p><p><strong><em>Cardiovascular and cerebrovascular effects</em></strong></p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy.</p><p>Clinical trial and epidemiological data suggest that use of some NSAIDs (particularly at high doses and in long term treatment) may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke). There are insufficient data to exclude such a risk for indomethacin.</p><p>Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with indomethacin after careful consideration. Similar consideration should be made before initiating longer-term treatment of patients with risk factors for cardiovascular disease (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking).</p><p><strong><em>Elderly:</em></strong></p><p>The elderly have an increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and perforation which may be fatal (see section 4.2).</p><p><strong><em>Respiratory disorders:</em></strong></p><p>Caution is required if administered to patients suffering from or with a previous history of bronchial asthma since NSAIDs have been reported to precipitate bronchospasm in such patients.</p><p><strong><em>Gastrointestinal bleeding, ulceration and perforation:</em></strong></p><p>GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at any time during treatment, with or without warning symptoms or previous history of serious GI events.</p><p>When GI bleeding or ulceration occurs in patients receiving indomethacin, the treatment should be withdrawn.</p><p>The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4.3), and in the elderly. These patients should commence treatment on the lowest dose available. Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant low dose aspirin, or other drugs likely to increase gastrointestinal risk (see below and section 4.5).</p><p>Patients with a history of GI toxicity, particularly&nbsp;<strong>when</strong>&nbsp;elderly, should report any unusual abdominal symptoms (especially GI bleeding) particularly in the initial stages of treatment.</p><p>Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticoseroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors or anti-platelet agents such as aspirin (see section 4.5).</p><p>NSAIDs should be given with care to patients with a history of gastrointestinal disease (ulcerative colitis, Crohn&#39;s disease) as these conditions may be exacerbated (see section 4.8).</p><p><strong><em>SLE and mixed connective tissue disease:</em></strong></p><p>In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis (see section 4.8).</p><p><strong><em>Dermatological:</em></strong></p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs (see section 4.8). Patients appear to be at highest risk for these reactions early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Indomethacin suppositories should be discontinued at the first appearance of skin rash, mucosal lesions, and any other sign of hypersensitivity.</p><p><strong><em>Impaired female fertility:</em></strong></p><p>The use of indomethacin may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of indomethacin should be considered.</p><p>Indomethacin should be used with caution in patients with coagulation defects as indomethacin can inhibit platelet aggregation. This effect may be exaggerated in patients with underlying haemostatic defects. Inhibition of platelet aggregation usually disappears within 24 hours of discontinuing indomethacin.</p><p>Caution is required in post-operative patients as bleeding time is prolonged (but within normal range) in normal adults.</p><p>During prolonged therapy, periodic ophthalmic examinations are recommended, as corneal deposits and retinal disturbances have been reported. In patients with rheumatoid arthritis, eye changes may occur which may be related to the underlying disease or to the therapy. Therefore, in chronic rheumatoid disease, ophthalmological examinations are periodic intervals are recommended. Therapy should be discontinued if eye changes are observed.</p><p>Patients should be periodically observed to allow early detection of any unwanted effects on peripheral blood (anaemia), liver function (also see section 4.8 Undesirable effects), or gastrointestinal tract especially during prolonged therapy.</p><p><strong>Medication Overuse Headache (MOH):</strong></p><p>After long term treatment with analgesics, headache may develop or aggravate. Headache caused by overuse of analgesics (MOH - medication-overuse headache) should be suspected in patients who have frequent or daily headaches despite (or because of) regular use of analgesics. Patients with medication overuse headache should not be treated by increasing the dose. In such cases the use of analgesics should be discontinued in consultation with a doctor.</p><p>Indomethacin should be used cautiously in patients with bleeding disorders, psychiatric disorders, epilepsy or parkinsonism, as it may tend to aggravate these.</p><p>Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p><p>Patients should be carefully observed to detect any unusual manifestations of drug sensitivity.</p><p>Indomethacin may mask the signs and symptoms of infection, so antibiotic therapy should be initiated promptly if an infection occurs during therapy with indomethacin. It should be used cautiously in patients with existing but controlled infection. Caution is advised with concomitant use of live vaccines.</p><p>Increases in plasma potassium concentration, including hyperkalaemia have been reported, even in some patients without renal impairment. In patients with normal renal function, these effects have been attributed to a hyporeninaemic-hypoaldosteronism state.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp; <strong>Other analgesics including cyclooxygenase-2 selective inhibitors:</strong> Avoid concomitant use of two or more NSAIDs (including aspirin) as this may increase the risk of adverse effects (see section 4.4).</p><p>&middot;&nbsp;&nbsp; <strong>Anti-coagulants:</strong> NSAIDs may enhance the effects of anti-coagulants, such as warfarin (see section 4.4).</p><p>&middot;&nbsp;&nbsp; <strong>Antidiabetics:</strong> the effect of sulphonylureas may be increased by NSAIDs.</p><p>&middot;&nbsp;&nbsp; <strong>Anti-hypertensives:</strong> Reduced anti-hypertensive effect. Indomethacin may acutely reduce the antihypertensive effect of beta-blockers due partly to indomethacin&#39;s inhibition of prostaglandin synthesis. Patients receiving dual therapy should have the antihypertensive effect of their therapy reassessed. Therefore, caution should be exercised when considering the addition of indomethacin to the regimen of a patient taking any of the following antihypertensive agents: alpha-adrenergic blocking agents, ACE inhibitors, beta-adrenergic blocking agents, angiotensin-2-receptor antagonists, hydralazine or nifedipine. An increased risk of hyperkalaemia has also been reported when NSAIDs are taken with ACE inhibitors.</p><p>&middot;&nbsp;&nbsp; <strong>Anti-platelet agents and selective serotonin reuptake inhibitors (SSRIs):</strong> Increased risk of gastrointestinal bleeding (see section 4.4).</p><p>&middot;&nbsp;&nbsp; <strong>Antipsychotics:</strong> increased drowsiness with indomethacin and haloperidol.</p><p>&middot;&nbsp;&nbsp; <strong>Antivirals:</strong> Risk of indomethacin toxicity with ritonavir, avoid concomitant use.</p><p>&middot;&nbsp;&nbsp; <strong>Cardiac Glycosides:</strong> NSAIDs may exacerbate cardiac failure, reduce GFR, and increase plasma glycoside levels.</p><p>&middot;&nbsp;&nbsp; <strong>Ciclosporin:</strong> Increased risk of nephrotoxicity. Administration of NSAIDs concomitantly with ciclosporin has been associated with an increase in ciclosporin-induced toxicity, possibly due to decreased synthesis of renal prostacyclin. NSAIDs should be used with caution in patients taking ciclosporin, and renal function should be monitored carefully.</p><p>&middot;&nbsp;&nbsp; <strong>Corticosteroids:</strong> increased risk of gastrointestinal ulceration or bleeding (see section 4.4). If the patient is receiving corticosteroids concomitantly, a reduction in dosage of these may be possible but should only be effected slowly under supervision.</p><p>&middot;&nbsp;&nbsp; <strong>Desmopressin:</strong> effect potentiated by indomethacin.</p><p>&middot;&nbsp;&nbsp; <strong>Diflunisal:</strong> avoid concomitant use. Increased plasma levels of indomethacin by about a third with a concomitant decrease in renal clearance occurs. Fatal gastro-intestinal haemorrhage has occurred.</p><p>&middot;&nbsp;&nbsp; <strong>Diuretics:</strong> NSAIDs may reduce the effect of diuretics and antihypertensive medicinal products. The risk of acute renal insufficiency, which is usually reversible, may be increased in some patients with compromised renal function (e.g. dehydrated patients or elderly patients) when angiotensin II receptor antagonists are combined with NSAIDs. Therefore, the combination should be administered with caution, especially in the elderly. Patients should be adequately hydrated and consideration should be given to monitoring of renal function after initiation of concomitant therapy, and periodically thereafter.</p><p>&middot;&nbsp;&nbsp; Indomethacin may reduce the diuretic and antihypertensive effect of thiazides and furosemide in some patients. Indomethacin may cause blocking of the furosemide-induced increase in plasma renin activity. Diuretics can increase the risk of nephrotoxicity of NSAIDs.</p><p>&middot;&nbsp;&nbsp; <strong>Lithium:</strong> Decreased elimination of lithium. Indomethacin is an inhibitor of prostaglandin synthesis and therefore the following drug interactions may occur; indomethacin may raise plasma lithium levels and reduce lithium clearance in subjects with steady state plasma lithium concentrations. At the onset of such combined therapy, plasma lithium concentration should be monitored more frequently.</p><p>&middot;&nbsp;&nbsp; <strong>Methotrexate:</strong> Decreased elimination of methotrexate.</p><p>&middot;&nbsp;&nbsp; <strong>Mifepristone:</strong> NSAIDs should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone.</p><p>&middot;&nbsp;&nbsp; Muscle Relaxants: increased risk of baclofen toxicity due to reduced rate of excretion.</p><p>&middot;&nbsp;&nbsp; <strong>Pentoxifylline:</strong> possible increased risk of bleeding when taken with NSAIDs.</p><p>&middot;&nbsp;&nbsp; <strong>Probenecid:</strong> co-administration with indomethacin may increase probenecid plasma levels. When increases in the dose of indomethacin are made under these circumstances, they should be made cautiously and in small increments.</p><p>&middot;&nbsp;&nbsp; <strong>Quinolone antibiotics:</strong> Animal data indicate the NSAIDs can increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions.</p><p>&middot;&nbsp;&nbsp; <strong>Salicylates:</strong> use of indomethacin with aspirin or other salicylates is not recommended because there is no enhancement of therapeutic effect while the incidence of gastro-intestinal side-effects is increased. Moreover, co-administration of aspirin may decrease the blood concentration of indomethacin.</p><p>&middot;&nbsp;&nbsp; <strong>Tacrolimus:</strong> Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.</p><p>&middot;&nbsp;&nbsp; <strong>Tiludronic acid:</strong> bisphosphonates bioavailability increased by indomethacin.</p><p>&middot;&nbsp;&nbsp; <strong>Triamterene:</strong> indomethacin and triamterene should not be administered together since reversible renal failure may be induced.</p><p>&middot;&nbsp;&nbsp; <strong><em>Zidovudine:</em></strong><strong>&nbsp;</strong>Increased risk of haematological toxicity when NSAIDs are given with zidovudine. There is evidence of an increased risk of haemarthroses and haematoma in HIV(+) haemophiliacs receiving concurrent treatment with zidovudine and ibuprofen.</p><p>&middot;&nbsp;&nbsp; Laboratory tests: false-negative results in the dexamethasone suppression test (DST) in patients being treated with indomethacin have been reported. Thus, results of this test should be used with caution in these patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em><u>Pregnancy</u></em></strong></p><p>Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk for cardiovascular malformation was increased from less than 1%, up to approximately 1.5%. The risk is believed to increase with dose and duration of therapy. In animals, administration of a prostaglandin synthesis inhibitor has been shown to result in increased pre- and post- implantation loss and embryo-foetal lethality. In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during the organogenetic period. During the first and second trimester of pregnancy, indomethacin should not be given unless clearly necessary. If indomethacin is used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.</p><p>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to:</p><p>-&nbsp; cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension);</p><p>-&nbsp; renal dysfunction, which may progress to renal failure with oligo-hydroamniosis;</p><p>&nbsp;the mother and the neonate, at the end of pregnancy to:</p><p>-&nbsp; possible prolongation of bleeding time, an anti-aggregating effect, which may occur even at very low doses</p><p>-&nbsp; inhibition of uterine contractions resulting in delayed or prolonged labour. Consequently indomethacin is contraindicated during the third trimester of pregnancy.</p><p><strong><em><u>Lactation:</u></em></strong></p><p>In limited studies so far available, NSAIDs can appear in breast milk in very low concentrations. NSAIDs should, if possible, be avoided when breastfeeding.</p><p>See section 4.4 Special warnings and precautions for use, regarding female fertility.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects such as dizziness, drowsiness, fatigue and visual disturbances are possible after taking NSAIDs. If affected, patients should not drive or operate machinery.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp; <strong><em>Blood and lymphatic disorders:</em></strong><em>&nbsp;</em>blood dyscrasias (such as thrombocytopenia,</p><p>neutropenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia), bone marrow depression, petechiae, ecchymoses, purpura, and disseminated intravascular coagulation may occur infrequently. As some patients manifest anaemia secondary to obvious or occult gastro-intestinal bleeding, appropriate blood determinations are recommended. Epistaxis has been reported rarely.</p><p>&middot;&nbsp;&nbsp; <strong><em>Hypersensitivity:</em></strong>&nbsp;Hypersensitivity reactions have been reported following treatment with NSAIDs. These may consist of (a) non-specific allergic reactions and anaphylaxis, (b) respiratory tract reactivity comprising asthma, aggravated asthma, bronchospasm or dyspnoea, rhinitis or (c) assorted skin disorders, including rashes of various types, pruritus, urticaria, purpura, angiodema and, more rarely exfoliative and bullous dermatoses (including epidermal necrolysis and erythema multiforme).</p><p>&middot;&nbsp;&nbsp; <strong><em>Metabolic and nutrition disorders:&nbsp;</em></strong>Hyperglycaemia, glycosuria, hyperkalaemia has been reported rarely.</p><p>&middot;&nbsp;&nbsp; <strong><em>Nervous system disorders:</em></strong><em>&nbsp;</em>Visual disturbances, optic neuritis, tinnitus, headache, dizziness and lightheadedness are common side effects<strong>.&nbsp;</strong>Starting therapy with a low dose and increasing gradually minimises the incidence of headache. These symptoms frequently disappear on continued therapy or reducing the dosage, but if headache persists despite dosage reduction, indomethacin should be withdrawn. Other CNS effects include reports of aseptic meningitis (especially in patients with existing autoimmune disorders, such as systemic lupus erythematosus or mixed connective tissue disease) with symptoms such as stiff neck, headache, nausea, vomiting, fever or disorientation (see section 4.4), depression, vertigo, fatigue, malaise, dysarthria, syncope, coma, cerebral oedema, nervousness<strong>,&nbsp;</strong>confusion, anxiety and other psychiatric disturbances, depersonalisation, hallucinations<strong>,&nbsp;</strong>drowsiness, convulsions and aggravation of epilepsy and parkinsonism, peripheral neuropathy, paraesthesia, involuntary movements and insomnia. These effects are often transient and abate or disappear on reduced or stopping treatment. However, the severity of these may, on occasion, require cessation of therapy<strong>.</strong></p><p>&middot;&nbsp;&nbsp; <strong><em>Eye disorders:</em></strong><em>&nbsp;</em>blurred vision, diplopia, optic neuritis and orbital and peri-orbital pain are seen infrequently. Corneal deposits and retinal or macular disturbances have been reported in some patients with rheumatoid arthritis on prolonged therapy with indomethacin. Ophthalmic examinations are desirable in patients given prolonged treatment.</p><p>&middot;&nbsp;&nbsp; <strong><em>Ear and labyrinth disorders:</em></strong><em>&nbsp;</em>tinnitus or hearing disturbances (rarely deafness) have been reported.</p><p>&middot;&nbsp;&nbsp; <strong><em>Cardiac disorders:</em></strong><em>&nbsp;</em>There have been reports of hypotension, tachycardia, chest pain, arrhythmia, palpitations.</p><p>&middot;&nbsp;&nbsp; <strong><em>Cardiovascular and cerebrovascular:</em></strong><strong> </strong>Oedema hypertension and cardiac failure have been reported in association with NSAID treatment.</p><p>&middot;&nbsp;&nbsp; <strong><em>Vascular disorders:</em></strong><em>&nbsp;</em>flushing has been reported rarely.</p><p>&middot;&nbsp;&nbsp; <strong><em>Respiratory, thoracic and mediastinal disorders</em></strong><strong>:</strong> pulmonary eosinophilia. There may be bronchospasm in patients with a history of bronchial asthma or other allergic disease.</p><p>&middot;&nbsp;&nbsp; <strong><em>Gastrointestinal disorders:</em></strong><em>&nbsp;</em>The most commonly-observed adverse events are gastrointestinal in nature. Anorexia, epigastric discomfort,ulceration at any point in the gastro-intestinal tract (even with resultant stenosis and obstruction), bleeding (even without obvious ulceration or from a diverticulum) and perforation of preexisting sigmoid lesions (such as diverticulum or carcinoma), increased abdominal pain or exacerbation of the condition in patients with ulcerative colitis or Crohns disease (or the development of this condition), intestinal strictures and regional ileitis have been rarely reported. Peptic ulcers, perforation or GI bleeding, sometimes fatal, particularly in the elderly, may occur (see section 4.4). If gastro-intestinal bleeding does occur treatment with indomethacin should be discontinued. Gastro-intestinal disorders which occur can be reduced by giving indomethacin with food, milk or antacids. Nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, exacerbation of colitis and Crohn&#39;s disease (See section 4.4) have been reported following administration. Less frequently, gastritis has been observed. Pancreatitis has been reported very rarely.</p><p>&middot;&nbsp;&nbsp; <strong><em>Hepato-biliary disorders:</em></strong><em>&nbsp;</em>cholestasis, borderline elevations of one or more liver tests may occur, and significant elevations of ALT (SGPT) or AST (SGOT) have been seen in less than 1% of patients receiving therapy with NSAIDs in controlled clinical trials. If abnormal liver tests persist or worsen, if clinical signs and symptoms consistent with liver disease develop, or if systemic manifestations such as rash or eosinophilia occur, indomethacin should be stopped. Abnormal liver function, hepatitis and jaundice.</p><p>&middot;&nbsp;&nbsp; <strong><em>Skin and subcutaneous tissue disorders:</em></strong><em>&nbsp;</em>pruritus, urticaria, angioneurotic oedema, angiitis, erythema nodosum, rash, photosensitivity, exfoliative dermatitis, bullous reactions including Stevens Johnson syndrome and Toxic Epidermal Necrolysis (very rare). Photosensitivity, erythema multiforme, hair loss, sweating and exacerbation of psoriasis.</p><p>&middot;&nbsp;&nbsp; <strong><em>Musculo-skeletal, connective tissue and bone disorders:</em></strong><em>&nbsp;</em>muscle weakness and acceleration of cartilage degeneration.</p><p>&middot;&nbsp;&nbsp; <strong><em>Renal and urinary disorders:</em></strong><em>&nbsp;</em>haematuria, nephrotoxicity in various forms, including interstitial nephritis, nephrotic syndrome and renal failure, renal insufficiency, proteinuria have all been reported. In patients with renal, cardiac or hepatic impairment, caution is required since the use of non-steroidal anti-inflammatory drugs may result in deterioration of renal function. The dose should be kept as low as possible and renal function should be monitored.</p><p>&middot;&nbsp;&nbsp; <strong><em>Reproductive system and breast disorders:</em></strong><em>&nbsp;</em>vaginal bleeding, breast changes (enlargement, tenderness, gynaecomastia)</p><p>&middot;&nbsp;&nbsp; Clinical trial and epidemiological data suggest that the use of some NSAIDs (particularly at high doses and in long term treatment) may be associated with an increased risk of arterial thrombotic events (for example myocardial infarction or stroke) (see section 4.4).</p><p>&nbsp;</p><p><strong><em><u>To report any side effect(s)</u></em></strong><strong><em><u>:</u></em></strong><strong><em><u> </u></em></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222, <strong>Exts:</strong> 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone:</strong> 8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Symptoms</u></strong></p><p>Symptoms include headache, nausea, vomiting, epigastric pain, gastrointestinal bleeding, rarely diarrhoea, disorientation, excitation, coma, drowsiness, dizziness, tinnitus, fainting, occasionally convulsions, abdominal pain, anorexia, restlessness and agitation. In cases of significant poisoning acute renal failure and liver damage are possible.</p><p><strong><u>Therapeutic measure</u></strong></p><p>Patients should be treated symptomatically as required.</p><p>Within one hour of ingestion of a potentially toxic amount, activated charcoal should be considered. Alternatively, in adults, gastric lavage should be considered within one hour of ingestion of a potentially life-threatening overdose.</p><p>Good urine output should be ensured.</p><p>Renal and liver function should be closely monitored.</p><p>Patients should be observed for at least four hours after ingestion of potentially toxic amounts.</p><p>Frequent or prolonged convulsions should be treated with intravenous diazepam.</p><p>Other measures may be indicated by the patient&#39;s clinical condition.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>ATC CODE:</em></strong><em> M01A B01</em></p><p>Indomethacin is a non-steroidal anti-inflammatory agent with analgesic and antipyretic properties.</p><p>The analgesic properties have been attributed to both central and peripheral effect, which are distinct from its anti-inflammatory activity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em><u>Absorption:</u></em></strong>&nbsp;Peak plasma concentrations of indomethacin are achieved in about 0.5-2 hours after a dose. Overall bioavailability of indomethacin rectally is 80%.</p><p><strong><em><u>Distribution:</u></em></strong>&nbsp;More than 90% is bound to plasma proteins. It is distributed into synovial fluid, CNS and placenta. Low concentrations have been found in breast mik.</p><p><strong><em><u>Metabolism:</u></em></strong>&nbsp;It is metabolised in the liver primarily by demethylation and deacetylation, it also undergoes glucuronidation and enterohepatic circulation. Half-life is between 3 &ndash; 11 hours.</p><p><strong><em><u>Elimination:</u></em></strong>&nbsp;Mainly excreted in the urine, approximately 60%, the pH of the urine can affect this amount. Lesser amounts in the faeces. Indomethacin is also excreted in milk in small amounts.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" align="left"><tbody><tr><td style="vertical-align:top"><p><strong><u>Inactive Ingredients:</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hard fat (estaram 8770 H15)</p></td></tr><tr><td style="vertical-align:top"><p>2.&nbsp;&nbsp; Polyoxyl 40 stearate</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None Known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months from the date of manufacturing.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&ordm;C. Protect from heat.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp; 5 Suppositories in an Alu-Alu strip, 2 strips packed in a printed carton along with a leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street.
Ras Al Khaimah - United Arab Emirates.
P.O. Box 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                19. May. 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>